| Absorption |
| Blood-Brain Barrier | BBB+ | 0.7385 |
| Human Intestinal Absorption | HIA+ | 0.9815 |
| Caco-2 Permeability | Caco2+ | 0.5847 |
| P-glycoprotein Substrate | Non-substrate | 0.5281 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9598 |
| Non-inhibitor | 0.7404 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8091 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8344 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7659 |
| CYP450 2D6 Substrate | Non-substrate | 0.8818 |
| CYP450 3A4 Substrate | Non-substrate | 0.6817 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.7957 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.6696 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7660 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5000 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7395 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5708 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9365 |
| Non-inhibitor | 0.8475 |
| AMES Toxicity | AMES toxic | 0.9108 |
| Carcinogens | Non-carcinogens | 0.8895 |
| Fish Toxicity | High FHMT | 0.9333 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.7073 |
| Honey Bee Toxicity | High HBT | 0.6772 |
| Biodegradation | Not ready biodegradable | 0.5468 |
| Acute Oral Toxicity | II | 0.4555 |
| Carcinogenicity (Three-class) | Non-required | 0.5990 |